focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: RWS and James Cropper sink on profit warnings

Wed, 23rd Mar 2022 11:21

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

4D Pharma PLC, up 37% at 61.45 pence, 12-month range 24.46p-135.00p. The pharmaceutical company says its therapeutic treatment MRx0518, in combination Merck's Keytruda, met its primary efficacy endpoint ahead of trial enrolment completion.

----------

AIM - LOSERS

----------

RWS Holdings PLC, down 27% at 342.00p, 12-month range 326.00p-701.00p. The technology-enabled language services provider warns its annual performance is set to be at the lower end of expectations.

RWS will no longer provide services or technology to Russian-owned businesses, and also expects reduced demand for translation into Russian from non-Russian owned companies. As a result, revenue growth from the Language Services unit is set to moderate, and RWS's overall performance for the year is anticipated to be at the lower end of market expectations.

----------

James Cropper PLC, down 18% at 1,002.00p, 12-month range 1,002.00p-1,650.00p. Shares in the paper products manufacturer hit a 12-month low as it warns it will miss previous expectations for profit. For the year ending March 26, James Cropper notes 30% growth in sales, ahead of prior market expectations due to strong demand across all divisions. However, it now expects adjusted pretax profit of GBP3.5 million, a sharp rise from GBP1.1 million the year before, but below prior expectations of GBP4.9 million. This is due to the conflict between Russia and Ukraine, and the resulting jump in energy costs, which affected the Paper division the most, due to being the most energy-intensive division.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
16 Jun 2015 07:56

4D Pharma Says Has Identified Potential Multiple Sclerosis Candidate

Read more
5 Jun 2015 11:04

4d Pharma posts losses of £2.38m in maiden results

Pharmaceutical company 4d Pharma has reported losses of £2.38m in its maiden set of full-year results. Basic losses per share totalled 4.81p. 4d, which uses selected bacteria to develop treatments, said that during the period its cash, cash equivalents, deposits and short-term investments increased

Read more
5 Jun 2015 09:13

4D Pharma Says "Excited" By Prospects In Maiden Full Year Results

Read more
20 May 2015 09:56

4d Pharma Submits Plans For Blautix Trial, Progressing With Thetanix

Read more
30 Mar 2015 14:53

4D Pharma Acquires Remaining Share In GT Biologics

Read more
9 Feb 2015 08:27

UK MORNING BRIEFING: Chinese And German Trade Figures Hit Shares

Read more
9 Feb 2015 06:15

UK AGM, EGM Calendar - Week Ahead

Read more
6 Feb 2015 16:01

UK AGM, EGM Calendar - Week Ahead

Read more
6 Feb 2015 06:17

UK AGM, EGM Calendar - Week Ahead

Read more
5 Feb 2015 16:00

UK AGM, EGM Calendar - Week Ahead

Read more
5 Feb 2015 06:24

UK AGM, EGM Calendar - Week Ahead

Read more
4 Feb 2015 15:58

UK AGM, EGM Calendar - Week Ahead

Read more
4 Feb 2015 06:15

UK AGM, EGM Calendar - Week Ahead

Read more
3 Feb 2015 16:00

UK AGM, EGM Calendar - Week Ahead

Read more
3 Feb 2015 06:15

UK AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.